Deal History
Über uns
Die Firma
Team
Büros
Globalscope
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Services
Corporate Finance
Debt Advisory
Aktienanalyse
Growth Equity
IPO Strategie und Vorbereitung
Industries
Business Services
Consumer & Internet
Industrial Technology
Life Science
Software & TMT
Energy & Infrastructure
Karriere
Events
Insights
News
Company News
Deal News
In den Medien
Newsletter
Kontakt
Newsletter
DE
INT
DA
FR
SV
US
Main menu button
Team
Deals
Kontakt
Team
Deals
Kontakt
News
Alle
Abera Bioscience
Adventure Box
Adverty
All for One Group
ALM Equity
Alzecure Pharma
Arctic Minerals
Biosergen
Candles Scandinavia
Carlsquare
CDON
CellaVision
CSAM Health Group
DanCann Pharma
Ecoclime
Elicera Therapeutics
Enrad
Frequentis
FRISQ
Future Gaming
GHP Specialty Care
GIAB
H&D Wireless
Hanza
Herantis Pharma
InCoax
Kancera
KlaraBo
Lokotech
Lokotech
Medclair Invest
Midsummer
Mindark PE
Modus Therapeutics
Moninvent
NeoDynamics
Nischer Properties
Nosa Plugs
Observit
Orion Corporation
Pharmiva
Raytelligence
Risk Intelligence
SBB i Norden
Sensec
Spotlight Group
Svenska Aerogel
Teneo AI
Thinc Jetty
Viva Wine Group
Ytrade Group
Zazz Energy
Zinzino
Alle
Company News
Deal News
Equity Research
Events
In den Medien
Insights
Märkte
30 Mrz 2022
Research Update InCoax Q4 2021: Continued order intake - but weaker revenues in Q4
Equity Research
InCoax